Abstract
Although there have been encouraging recent studies showing a potential benefit from annual mammography in women aged 40–49 years of age with an elevated breast cancer risk due to family history there is little evidence of efficacy in women aged <40 years of age. A prospective study (FH02) has been developed to assess the efficacy of mammography screening in women aged 35–39 years of age with a lifetime breast cancer risk of ≥17 % who are not receiving MRI screening. Retrospective analyses from five centres with robust recall systems identified 47 breast cancers (n = 12 in situ) with an interval cancer rate of 15/47 (32 %). Invasive tumour size, lymph node status and current vital status were all significantly better than in two control groups of unscreened women (including those with a family history) recruited to the POSH study. Further evaluation of the prospective arm of FH02 is required to assess the potential added value of digital mammography and the cancer incidence rates in moderate and high risk women in order to inform cost effectiveness analyses.
Similar content being viewed by others
References
McIntosh A, Shaw C, Evans G, et al (2006) Clinical guidelines and evidence review for the classification and care of women at risk of familial breast cancer, National Collaborating Centre for Primary Care/University of Sheffield, London. NICE guideline CG041. www.nice.org.uk
Mackay J, Rogers C, Fielder H et al (2001) Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer. J Epidemiol Biostat 6:365–369
FH01 management committee, steering committee and collaborators (2006) The challenge of evaluating annual mammography screening for young women with a family history of breast cancer. J Med Screen 13:177–182
FH01 collaborative teams (2010) Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. Lancet Oncol 11:1127–1134
Wald NJ, Murphy P, Major P et al (1995) UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. BMJ 311:1189–1193
Pisano ED, Gatsonis C, Hendrick E et al (2005) Diagnostic performance of digital versus film mammography for breast cancer screening. N Engl J Med 353:1773–1783
Leach MO, Boggis CR, Dixon AK et al (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365:1769–1778
Gilbert FJ, Astley SM, Gillan MG et al (2008) Single reading with computer aided detection for screening mammography. N Engl J Med 359:1675–1684
Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L, Trial Management Group (2006) Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years’ follow-up: a randomised controlled trial. Lancet 368:2053–2060
Law J, Faulkner K, Young KC (2007) Risk factors for induction of breast cancer by X-rays and their implications for breast screening. Br J Radiol 80(952):261–266
Maurice A, Evans DGR, Shenton A, Boggis C, Wilson M, Duffy S, Howell A (2006) The screening of women aged less than 50 years at increased risk of breast cancer by virtue of their family history. Eur J Cancer 42:1385–1390
Maurice A, Evans DG, Affen J, Greenhalgh R, Duffy SW, Howell A (2012) Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: further evidence of benefit. Int J Cancer 131:417–425
Eccles D, Gerty S, Simmonds P, Hammond V, Ennis S, Altman DG, POSH steering group (2007) Prospective study of outcomes in sporadic versus hereditary breast cancer (POSH): study protocol. BMC Cancer 7:160
Claus EB, Risch N, Thompson WD (1994) Autosomal dominant inheritance of early onset breast cancer. Cancer 73:643–651
Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23:1111–1130
Amir E, Evans DG, Shenton A et al (2003) Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40:807–814
Eccles DM, Evans DGR, Mackay J (2000) Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. J Med Genet 37:203–209
Pharoah P, Day NE, Duffy S et al (1997) Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 71:800–809
Day NE, Walter SD (1984) Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics 43:1–13
Day N, McCann J, Camilleri-Ferrante C et al (1995) Monitoring interval cancers in breast screening programmes: the east Anglian experience. Quality assurance management group of the east anglian breast screening programme. Med Screen 2:180–185
Paci E, Warwick J, Falini P, Duffy SW (2004) Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern? J Med Screen 11:23–27
Brain K, Henderson BJ, Tyndel S, Bankhead C, Watson E, Clements A, Austoker J, PIMMS Study Management Group (2008) Predictors of breast cancer-related distress following mammography screening in younger women on a family history breast screening programme. Psychooncology 17:1180–1188
Moss S, Waller M, Anderson TJ, Cuckle H, Trial Management Group (2005) Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures. Br J Cancer. 92:955–960
Bjurstam N, Bjorneld L, Duffy SW et al (1997) The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39–49 years at randomization. Cancer 80:2091–2099
Paci E, Duffy SW (1991) Modelling the analysis of breast cancer screening programmes: sensitivity, lead time and predictive value in the Florence District Programme (1975–1986). Int J Epidemiol 20:852–858
Norman RP, Evans DG, Easton DF, Young KC (2007) The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30–49. Eur J Health Econ 8:137–144
Taylor L, Basro S, Apffelstaedt JP, Baatjes K (2011) Time for a re-evaluation of mammography in the young? Results of an audit of mammography in women younger than 40 in a resource restricted environment. Breast Cancer Res Treat 129:99–106
Hellquist BN, Duffy SW, Nyström L, Jonsson H (2012) Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in Sweden. J Med Screen 19:14–19
Acknowledgments
We thank Breast Cancer Campaign for funding the FH02 study. Prof Gareth Evans is an NIHR senior investigator.
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Please see the “Appendix” section for FH02 study group authors.
Appendix
Appendix
FH02 study group authors
Airedale NHS Foundation Trust | Eleanor Waldron | |
---|---|---|
Ardmillan Screening Centre, Edinburgh | Dr Lesley Smart | Lynda Luke |
Birmingham | Mrs Simerjit Rai | |
Bradford | Dr Richard Linforth | |
BTW Cardiff | Guy Stevens | Jane Evans |
BTW Llandudno | Guy Stevens | Jane Evans |
BTW Singleton | Guy Stevens | Jane Evans |
Burton, Queen’s Hospital | Dr Nick Luft | None |
Chester | Ms Hollie Devlin | |
Craigavon Area Hospital, Northern Ireland | Dr Cathy Farnon | Ruth Hall |
Derby | Wendy Chorley | Diana Mayor |
Great Ormond Street/Barts | Dr Vian Salih | |
Grantham District Hospital | Mr N Potdar | Mr A Modi |
Hope Hospital, Salford | Joy Hunter | |
Kettering | Mr Mohammed Rashed | |
Leeds | Mr Philip Turton | Mrs Sue Hartup |
Leicester | Dr Julian Barwell | |
Leighton Hospital, Crewe | Tracey Hale | |
Newcastle | Dr Alex Henderson | Irene Jobson |
Northwick Park Hospital | Mr William Teh | |
Nottingham | Mr R.D Macmillan | |
Pilgrim Hospital Boston Lincs | Mr N Potdar | Mrs Ambika Anand |
Portsmouth | Carmel Sheppard | |
Royal Devon & Exeter | Di Cameron | Mary Davies |
Royal Liverpool University Hospital | Sue Holcombe | Laura Francis |
Royal Marsden Hospital, London | Mr Gerald Gui | Dr Janet Self |
Royal United Hospital, Bath | Dr Diana Dalgliesh | Katherine Knight |
Southend | Mr Neil Rothnie | |
Truro | Dr D Christensen | |
Ulster | Dr Janet Newell | Ethna McFerran |
University Hospital of South Manchester | Rosemary Greenhalgh | Jenny Affen |
University Hospitals Coventry & Warwickshire NHS Trust | Celia Lewis | |
Whiston Hospital, Prescot, Merseyside | Riccardo Audisio |
Rights and permissions
About this article
Cite this article
Evans, D.G., Thomas, S., Caunt, J. et al. Mammographic surveillance in women aged 35–39 at enhanced familial risk of breast cancer (FH02). Familial Cancer 13, 13–21 (2014). https://doi.org/10.1007/s10689-013-9661-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-013-9661-8